Section Navigation
Section Navigation
- Module 4 Overview
Co-Occurring Conditions - 0%Lesson 1
Latent Tuberculosis InfectionActivities- 0%Lesson 2
Opportunistic Infections: PreventionActivities- 0%Lesson 3
Opportunistic Infections: TreatmentActivities- 0%Lesson 4
Sexually Transmitted InfectionsActivities- 0%Lesson 5
Hepatitis B CoinfectionCo-Occurring Conditions Overview3rd Edition
Module Core Competency
Apply Evidence-Based Recommendations for the Evaluation and Management of Co-Occurring Conditions in Persons with HIV Infection
Target Audience
The Co-Occurring Conditions module addresses the prevention and management of infectious and non-infectious complications in persons with HIV infection.Editor
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures: NoneFree CNE/CME
Available in theModule Lessons
1Lesson 1 Latent Tuberculosis Infection
- Learning Objectives
- Discuss the epidemiology of tuberculosis and HIV coinfection in the United States
- State the rationale for screening for latent TB in people with HIV
- Describe and compare recommended screening tests for latent TB in people with HIV
- List recommended options for the treatment of latent TB in people with HIV
- Summarize common drug interactions between medications used to treat latent TB and common antiretroviral medications
- Quick ReferenceLatent Tuberculosis Infection Core Concepts
2Lesson 2 Opportunistic Infections: Prevention
- Learning Objectives
- Discuss recommendations for initiating primary prevention of opportunistic infections in people with HIV
- Summarize recommendations for initiating secondary prophylaxis of opportunistic infections in people with HIV
- State criteria for discontinuing primary prevention of opportunistic infections in people with HIV
- List criteria for discontinuing secondary prophylaxis of opportunistic infections in people with HIV
- Recognize potential adverse effects and contraindications for medications used for prevention of opportunistic infections
- Quick ReferenceOpportunistic Infections: Prevention Core Concepts
3Lesson 3 Opportunistic Infections: Treatment
- Learning Objectives
- Describe trends in the incidence of opportunistic infections in people with HIV
- Recognize the clinical manifestations of common serious opportunistic infections that occur in people with HIV
- Discuss recommended treatment of common opportunistic infections
- List indications for discontinuing treatment for opportunistic infections
- Summarize recommendations for initiating antiretroviral therapy in the setting of an active opportunistic infection
- Quick ReferenceOpportunistic Infections: Treatment Core Concepts
- Background
- Pneumocystis Pneumonia
- Toxoplasma gondii Encephalitis
- Disseminated Mycobacterium avium Complex Disease
- Cryptococcosis
- Cytomegalovirus Disease
- Progressive Multifocal Leukoencephalopathy
- Esophageal Candidiasis
- Histoplasmosis
- Bartonella
- Coccidiomycosis
- Cryptosporidiosis
- Microsporidiosis
- Cystoisosporiasis (formerly Isosporiasis)
- Summary Points
4Lesson 4 Sexually Transmitted Infections
- Learning Objectives
- Describe the recommendations for sexually transmitted infection screening in people with HIV
- Summarize CDC recommendations for the treatment of common sexually transmitted infections in people with HIV
- Explain the different stages of syphilis and the recommended treatments at each stage
- Discuss laboratory-based methods for diagnosing syphilis
- List recommended treatment and suppressive treatment options for genital herpes in people with HIV
- Quick ReferenceSexually Transmitted Infections Core Concepts
5Lesson 5 Hepatitis B Coinfection
- Learning Objectives
- Identify appropriate tests for evaluation of hepatitis B virus (HBV) infection and immunity
- Summarize the approach to persons with HIV who have isolated hepatitis B core antibody
- Discuss antiretroviral management of persons with HIV and HBV coinfection
- Describe HBV-related immune reconstitution syndrome
- List indications and methods for hepatocellular carcinoma surveillance in persons with chronic HBV and HIV coinfection
- Quick ReferenceHepatitis B Coinfection Core Concepts
- Background
- Screening for HBV in Persons with HIV
- Initial Evaluation of Persons with HBV and HIV Coinfection
- Treatment of HBV and HIV in Persons with HIV and HBV Coinfection
- Monitoring HBV Treatment Response
- Management of HIV or HBV Virologic Failure
- Stopping HBV Treatment and Hepatic Flares
- HBV-Related Immune Reconstitution Syndrome (HBV-IRIS)
- Hepatitis D Virus
- Preventing HBV Perinatal Transmission
- Surveillance for Hepatocellular Carcinoma
- Managing Persons with Coinfection and Advanced Liver Disease
- Summary Points
- Activity 5B.Hepatitis Delta Infection
6Lesson 6 Hepatitis C Coinfection
- Learning Objectives
- Explain recommendations for HCV screening in people with HIV
- Describe the appropriate HCV testing algorithm
- Summarize the eligibility criteria and current guidelines for the simplified HCV treatment in people with HIV
- Discuss simplified HCV treatment regimens options for people with HIV
- List indications and methods for hepatocellular carcinoma surveillance in persons with chronic HCV and HIV
- Quick ReferenceHepatitis C Coinfection Core Concepts
- Background and Epidemiology
- Natural History of HIV-HCV Coinfection
- Screening for HCV Infection
- HCV Diagnostic Testing
- Evaluation of Persons Diagnosed with HCV Coinfection
- Treatment of HIV in Persons with HCV Coinfection
- Treatment of HCV in Persons with HIV Coinfection
- Monitoring and Management of Chronic Liver Disease
- Special Considerations During Pregnancy
- Summary Points
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Funded by
Health Resources and Services Administration (HRSA)
Created at
University of Washington
An AETC Program
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 National HIV Curriculum
The National HIV Curriculum is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1,172,990 with 0% financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-a3460488-2024-11-13-205621